uploads///Part  Graph

XBI Had the Best Trading Day Year-to-Date


Apr. 7 2016, Updated 3:03 p.m. ET

XBI’s best trading day

The markets ended high as biotechnology and energy stocks surged. The Dow Jones Industrial Average gained 0.6% on April 6, 2016. Oil prices also ended high as the Fed indicated that a rate hike in April is unlikely. Biotech and healthcare stocks were the highlights of the day along with energy stocks. The SPDR S&P Biotech ETF (XBI) witnessed the best trading day year-to-date in terms of gains. Finally, Pfizer (PFE) and Allergan (AGN) confirmed that they have called off the merger.

Article continues below advertisement

The above chart shows the SPDR S&P Biotech ETF, the SPDR S&P 500 ETF, and some of XBI’s top gainers on April 6, 2016. XBI closed at $57.59 and was trading above the 20-day moving average. With this gain, the fund has cut down its year-to-date loss from ~25% to ~18%. Out of 101 stocks in XBI’s portfolio, 100 stocks advanced on April 6, 2016.

Top gainers

The top gainers within XBI include Raptor Pharmaceuticals (RPTP), Sarepta Therapeutics (SRPT), and Anacor Pharmaceuticals (ANAC), which went up by 24.4%, 19.3%, and 16.5%, respectively. Raptor Pharmaceuticals went up on news that the company is in talks with investment banks for a possible sale. Raptor Pharmaceuticals closed at $5.81 and was trading above its 20-day and 100-day moving averages. Year-to-date, the stock has outperformed with a return of 11.7%. Nearly 3.2 million shares were traded for the day. The relative strength index of the stock is at 76, indicating that the stock has moved into an overbought situation. The book value of the stock is at $1.37 per share. With its current price, the stock is trading at a price-to-book value (or PBV) of ~4.2x. It has a weight of ~0.4% in XBI’s portfolio.


More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.